Cargando…

No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used

Polycystic ovary syndrome (PCOS) is characterized by the presence of insulin resistance, and women with PCOS have high prevalence of gestational diabetes (GDM). Both conditions have been associated with increased risk for pregnancy complications such as preterm birth, preeclampsia and increased offs...

Descripción completa

Detalles Bibliográficos
Autores principales: Fougner, Stine Lyngvi, Vanky, Eszter, Løvvik, Tone Shetelig, Carlsen, Sven Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301673/
https://www.ncbi.nlm.nih.gov/pubmed/34297751
http://dx.doi.org/10.1371/journal.pone.0254895
_version_ 1783726725093392384
author Fougner, Stine Lyngvi
Vanky, Eszter
Løvvik, Tone Shetelig
Carlsen, Sven Magnus
author_facet Fougner, Stine Lyngvi
Vanky, Eszter
Løvvik, Tone Shetelig
Carlsen, Sven Magnus
author_sort Fougner, Stine Lyngvi
collection PubMed
description Polycystic ovary syndrome (PCOS) is characterized by the presence of insulin resistance, and women with PCOS have high prevalence of gestational diabetes (GDM). Both conditions have been associated with increased risk for pregnancy complications such as preterm birth, preeclampsia and increased offspring birth weight. We aimed to estimate the prevalence of GDM in women with PCOS using both previous and new diagnostic criteria, and to analyse whether the risk of pregnancy complications increased with the presence of GDM. In addition, we aimed to assess the response to metformin treatment in PCOS women with GDM. We performed post-hoc analysis of three prospective, double blinded studies of altogether 791 pregnant women with PCOS randomized to either metformin or placebo treatment from first trimester to delivery. Glucose data allowing GDM classification after previous (WHO 1999) and new (WHO 2013 and Norwegian 2017) diagnostic criteria were available for 722 of the women. Complications such as preeclampsia, late miscarriage and preterm birth, birth weight and gestational age were correlated to the presence of GDM and metformin treatment. The prevalence of GDM was 28.3% (WHO 1999), 41.2% (WHO 2013) and 27.2% (Norwegian 2017). Having GDM already in first trimester associated with increased risk for late miscarriage (p<0.01). Having GDM according to newer criteria correlated to increased maternal age and BMI (p<0.001). Otherwise, having GDM (any criteria) correlated neither to the development of preeclampsia, nor to birth weight z-score or the proportion of offspring being large for gestational weight. Maternal age and BMI, parity and gestational weight gain, but not GDM or metformin treatment, were determinants for birth weight z-score. Conclusion: in pregnant women with PCOS, having GDM did not increase the risk for other pregnancy complications except for an increased risk for late miscarriage among those with GDM already in the first trimester.
format Online
Article
Text
id pubmed-8301673
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83016732021-07-31 No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used Fougner, Stine Lyngvi Vanky, Eszter Løvvik, Tone Shetelig Carlsen, Sven Magnus PLoS One Research Article Polycystic ovary syndrome (PCOS) is characterized by the presence of insulin resistance, and women with PCOS have high prevalence of gestational diabetes (GDM). Both conditions have been associated with increased risk for pregnancy complications such as preterm birth, preeclampsia and increased offspring birth weight. We aimed to estimate the prevalence of GDM in women with PCOS using both previous and new diagnostic criteria, and to analyse whether the risk of pregnancy complications increased with the presence of GDM. In addition, we aimed to assess the response to metformin treatment in PCOS women with GDM. We performed post-hoc analysis of three prospective, double blinded studies of altogether 791 pregnant women with PCOS randomized to either metformin or placebo treatment from first trimester to delivery. Glucose data allowing GDM classification after previous (WHO 1999) and new (WHO 2013 and Norwegian 2017) diagnostic criteria were available for 722 of the women. Complications such as preeclampsia, late miscarriage and preterm birth, birth weight and gestational age were correlated to the presence of GDM and metformin treatment. The prevalence of GDM was 28.3% (WHO 1999), 41.2% (WHO 2013) and 27.2% (Norwegian 2017). Having GDM already in first trimester associated with increased risk for late miscarriage (p<0.01). Having GDM according to newer criteria correlated to increased maternal age and BMI (p<0.001). Otherwise, having GDM (any criteria) correlated neither to the development of preeclampsia, nor to birth weight z-score or the proportion of offspring being large for gestational weight. Maternal age and BMI, parity and gestational weight gain, but not GDM or metformin treatment, were determinants for birth weight z-score. Conclusion: in pregnant women with PCOS, having GDM did not increase the risk for other pregnancy complications except for an increased risk for late miscarriage among those with GDM already in the first trimester. Public Library of Science 2021-07-23 /pmc/articles/PMC8301673/ /pubmed/34297751 http://dx.doi.org/10.1371/journal.pone.0254895 Text en © 2021 Fougner et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Fougner, Stine Lyngvi
Vanky, Eszter
Løvvik, Tone Shetelig
Carlsen, Sven Magnus
No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
title No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
title_full No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
title_fullStr No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
title_full_unstemmed No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
title_short No impact of gestational diabetes mellitus on pregnancy complications in women with PCOS, regardless of GDM criteria used
title_sort no impact of gestational diabetes mellitus on pregnancy complications in women with pcos, regardless of gdm criteria used
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301673/
https://www.ncbi.nlm.nih.gov/pubmed/34297751
http://dx.doi.org/10.1371/journal.pone.0254895
work_keys_str_mv AT fougnerstinelyngvi noimpactofgestationaldiabetesmellitusonpregnancycomplicationsinwomenwithpcosregardlessofgdmcriteriaused
AT vankyeszter noimpactofgestationaldiabetesmellitusonpregnancycomplicationsinwomenwithpcosregardlessofgdmcriteriaused
AT løvviktoneshetelig noimpactofgestationaldiabetesmellitusonpregnancycomplicationsinwomenwithpcosregardlessofgdmcriteriaused
AT carlsensvenmagnus noimpactofgestationaldiabetesmellitusonpregnancycomplicationsinwomenwithpcosregardlessofgdmcriteriaused